What to Know About Treating Seasonal Affective Disorder
Paul Desan, PhD, associate professor of psychiatry and director of the Winter Depression Research Clinic at Yale School of Medicine, spoke to PBS News about why some people suffer from Seasonal Affective Disorder, or SAD, a recurrent form of depression that emerges in the winter.Source: PBS News
Ketamine and the Neurobiology of Depression: Toward Next-generation Rapid-acting Antidepressant Treatments
John Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research and Professor of Psychiatry, of Neuroscience, and of Psychology; and Irina Esterlis, PhD, associate professor of psychiatry, are first and senior authors, respectively, of a review published in Proceedings of the National Academy of Sciences Perspective that considers what scientists have learned from studies of ketamine and to suggest future directions for the optimization of rapid-acting antidepressant treatment.Source: Proceedings of the National Academy of Sciences Perspective
Sanacora, Wilkinson Receive $12.6M in Funding for Ketamine Study
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, and Samuel Wilkinson, MD, associate professor of psychiatry, have received $12.6 million in funding from the Patient-Centered Outcomes Research Institute (PCORI) for the study, “Comparative Effectiveness of Racemic Ketamine versus S-Ketamine (Spravato) for Depression.”
Supplying a High: Nitrous Oxide Abuse Chokes With Colorful and Dangerous Highs
Amir Garakani, MD, associate professor of psychiatry and chair of psychiatry and behavioral health at Greenwich Hospital, spoke to WVUE-Fox 8 about the potential health risks associated with frequent nitrous oxide use.Source: WVUE-Fox 8
PRCH Representatives Collaborate With City, Local Artist to Create Mural in New Haven
Representatives of the Yale Program for Recovery and Community Health (PRCH) and the City of New Haven’s Office of Community Mental Initiatives worked with an artist to create a 50-foot mural at the corner of Blatchley and Grand avenues in New Haven.
Multi-ancestry Genome-wide Association Study of Cannabis Use Disorder Yields Insight Into Disease Biology and Public Health Implications
In a landmark research study, scientists have unveiled the results of a comprehensive genome-wide association study (GWAS), published in Nature Genetics, shedding new light on the genetic factors underlying cannabis use disorders (CanUD) and their potential link to lung cancer.
Ketamine Effectively Treats Depression. Do the Benefits Outweigh the Risks?
Sophie Holmes, PhD, assistant professor of psychiatry, told National Geographic that continued research is needed to determine who might benefit from being treated by ketamine, the drug often prescribed in cases of severe depression and anxiety.Source: National Geographic
Yale Psychiatry Researchers Awarded Grant to Establish PRISM Initiative
Yale Department of Psychiatry researchers have been awarded a three-year federal grant to establish the Partnered Evaluation of Relationship Health Innovations and Services through Mixed Methods (PRISM) Initiative. Galina Portnoy, PhD, assistant professor of psychiatry, is the principal investigator on the PRISM Initiative, a $1.63 million grant supported by the Quality Enhancement Research Initiative (QUERI) and VA’s Care Management and Social Work Service Intimate Partner Violence Assistance Program (IPVAP).
Yale Researchers Propose Epistemic Justice as Key to Mental Health System Overhaul
In a new chapter for the book “Recovering the US Mental Healthcare System,” Rebecca Miller, PhD, associate professor of psychiatry, and Anthony Pavlo, PhD, associate research scientist in psychiatry, explore the transformative potential of epistemic justice in moving mental healthcare systems past traditional medical models.Source: Mad in America
In Memoriam: Miraj U. Desai, PhD
It is with immense sadness that the Yale Department of Psychiatry shares the news of the sudden death of Miraj Desai, PhD, at the age of 41 on Sunday, November 5, 2023. Miraj was an assistant professor at the Program for Recovery and Community Health (PRCH) of the Yale University School of Medicine, Department of Psychiatry.
LaPaglia Delivers Keynote at Meeting of Indonesian Clinical Psychologist Association
Donna LaPaglia, PsyD, associate professor of psychiatry, delivered a keynote at the 5th National Scientific Meeting of the Indonesian Clinical Psychologist Association on “Substance Use Disorders and Systems of Care" held October 28 in Bali, Indonesia.
Electronic Nicotine Delivery Systems and E-Liquid Modifications to Vape Cannabis Depicted in Online Videos
Rachel Ouellette, PhD; Sophia Selino, BA; and Grace Kong, PhD, are co-authors of a paper in JAMA Network Open that analyzed YouTube videos for use, modification, and marketing of electronic nicotine delivery systems to vape cannabis.Source: JAMA Network Open
This Psychologist is Training Supervisors in the Dynamics of Power and Privilege, and How Those Can Play Out in Their Work With Students
Amber Childs, PhD, assistant professor of psychiatry, spoke to the American Psychological Association for a story about the GROW (Getting Racism Out of Work) Initiative, which she co-founded.Source: American Psychological Association
Yale Study Finds Genetic Links Between Some Health Conditions and PTSD
A new study led by Yale Department of Psychiatry researchers and published in JAMA Psychiatry has identified numerous physical health conditions, particularly diseases of the cardiovascular and respiratory systems, that have genetic links to post-traumatic stress disorder (PTSD). Gita Pathak, PhD, and Renato Polimanti, PhD, are first and senior authors, respectively.
NIDA Invests Nearly $7M to Address the Opioid Crisis Among Women Who Experience Intimate Partner Violence
The National Institutes of Health and National Institute on Drug Abuse has awarded nearly $7 million to MPIs Tami Sullivan, PhD (Psychiatry and Public Health); E. Jennifer Edelman, MD, MHS (Internal Medicine and Public Health); and Dawn Johnson, PhD (University of Akron Department of Psychology) to study medication for opioid use disorder treatment retention among women who experience intimate partner violence.